Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by Massachusetts General Hospital
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Theodore Sunki Hong, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01821729
First received: March 27, 2013
Last updated: January 18, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)